Table 4.
AUC of TMAO, choline, L-carnitine, and betaine for predicting CAD in all, male, and female participants.
| AUC | 95% CI | p | |
|---|---|---|---|
| All | |||
| TMAO | 0.6 | 0.52–0.69 | 0.03 |
| TMAO + choline + L-carnitine + betaine | 0.64 | 0.56–0.72 | <0.01 |
| Male | |||
| TMAO | 0.64 | 0.51–0.77 | 0.04 |
| TMAO + choline + L-carnitine + betaine | 0.64 | 0.52–0.77 | 0.04 |
| Female | |||
| TMAO | 0.57 | 0.46–0.69 | 0.21 |
| TMAO + choline + L-carnitine + betaine | 0.64 | 0.53–0.75 | 0.02 |